METHOTREXATE (METHOTREXATE SODIUM) — all Canadian products
76 DINs
47 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is METHOTREXATE (METHOTREXATE SODIUM), with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02530775 | METHOFILL SELF-DOSE INJECTOR | ACCORD HEALTHCARE INC | Solution | Subcutaneous | METHOTREXATE (METHOTREXATE SODIUM) 10 MG | Marketed | |
| 02530767 | METHOFILL SELF-DOSE INJECTOR | ACCORD HEALTHCARE INC | Solution | Subcutaneous | METHOTREXATE (METHOTREXATE SODIUM) 7.5 MG | Approved | |
| 02530848 | METHOFILL SELF-DOSE INJECTOR | ACCORD HEALTHCARE INC | Solution | Subcutaneous | METHOTREXATE (METHOTREXATE SODIUM) 22.5 MG | Marketed | |
| 02530813 | METHOFILL SELF-DOSE INJECTOR | ACCORD HEALTHCARE INC | Solution | Subcutaneous | METHOTREXATE (METHOTREXATE SODIUM) 20 MG | Marketed | |
| 02530805 | METHOFILL SELF-DOSE INJECTOR | ACCORD HEALTHCARE INC | Solution | Subcutaneous | METHOTREXATE (METHOTREXATE SODIUM) 17.5 MG | Marketed | |
| 02530791 | METHOFILL SELF-DOSE INJECTOR | ACCORD HEALTHCARE INC | Solution | Subcutaneous | METHOTREXATE (METHOTREXATE SODIUM) 15 MG | Marketed | |
| 02530783 | METHOFILL SELF-DOSE INJECTOR | ACCORD HEALTHCARE INC | Solution | Subcutaneous | METHOTREXATE (METHOTREXATE SODIUM) 12.5 MG | Marketed | |
| 02530856 | METHOFILL SELF-DOSE INJECTOR | ACCORD HEALTHCARE INC | Solution | Subcutaneous | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Marketed | |
| 02283697 | METHOTREXATE | APOTEX INC | Tablet | Oral | METHOTREXATE (METHOTREXATE SODIUM) 2.5 MG | Approved | |
| 02327236 | METHOTREXATE INJECTION BP | ACCORD HEALTHCARE INC | Solution | Intra-Arterial; Intracerebroventricular; Intrathecal; Intramuscular; Intravenous | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Marketed | |
| 02464365 | METHOTREXATE INJECTION BP | ACCORD HEALTHCARE INC | Solution | Intramuscular; Intra-Arterial; Intravenous | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Marketed | |
| 02474735 | METHOTREXATE INJECTION BP | ACCORD HEALTHCARE INC | Solution | Intravenous | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Marketed | |
| 02474891 | METHOTREXATE INJECTION BP | ACCORD HEALTHCARE INC | Solution | Intravenous | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Marketed | |
| 02333023 | METHOTREXATE INJECTION BP | UMAN PHARMA INC | Solution | Intra-Arterial; Intramuscular; Intravenous; Intrathecal | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Approved | |
| 02182955 | METHOTREXATE INJECTION USP | PFIZER CANADA ULC | Solution | Intrathecal; Intra-Arterial; Intramuscular; Intracerebroventricular; Intravenous | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Marketed | |
| 02182971 | METHOTREXATE INJECTION USP | PFIZER CANADA ULC | Solution | Intravenous | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Marketed | |
| 02182777 | METHOTREXATE INJECTION USP | PFIZER CANADA ULC | Solution | Intravenous; Intramuscular; Intra-Arterial | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Marketed | |
| 02182947 | METHOTREXATE INJECTION USP | PFIZER CANADA ULC | Solution | Intravenous; Intracerebroventricular; Intra-Arterial; Intramuscular; Intrathecal | METHOTREXATE (METHOTREXATE SODIUM) 10 MG | Marketed | |
| 02422190 | METHOTREXATE INJECTION, BP | PHARMASCIENCE INC | Solution | Intravenous; Intramuscular | METHOTREXATE (METHOTREXATE SODIUM) 20 MG | Marketed | |
| 02422204 | METHOTREXATE INJECTION, BP | PHARMASCIENCE INC | Solution | Intravenous; Intramuscular | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Marketed | |
| 02422166 | METHOTREXATE INJECTION, BP | PHARMASCIENCE INC | Solution | Intravenous; Intramuscular | METHOTREXATE (METHOTREXATE SODIUM) 7.5 MG | Marketed | |
| 02422174 | METHOTREXATE INJECTION, BP | PHARMASCIENCE INC | Solution | Intramuscular; Intravenous | METHOTREXATE (METHOTREXATE SODIUM) 10 MG | Marketed | |
| 02422182 | METHOTREXATE INJECTION, BP | PHARMASCIENCE INC | Solution | Intravenous; Intramuscular | METHOTREXATE (METHOTREXATE SODIUM) 15 MG | Marketed | |
| 02099705 | METHOTREXATE SODIUM INJECTION | TEVA CANADA LIMITED | Solution | Intra-Arterial; Intramuscular; Intracerebroventricular; Intravenous; Intrathecal | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Marketed | |
| 02491338 | METHOTREXATE SUBCUTANEOUS | ACCORD HEALTHCARE INC | Solution | Subcutaneous | METHOTREXATE (METHOTREXATE SODIUM) 17.5 MG | Marketed | |
| 02491346 | METHOTREXATE SUBCUTANEOUS | ACCORD HEALTHCARE INC | Solution | Subcutaneous | METHOTREXATE (METHOTREXATE SODIUM) 20 MG | Marketed | |
| 02491354 | METHOTREXATE SUBCUTANEOUS | ACCORD HEALTHCARE INC | Solution | Subcutaneous | METHOTREXATE (METHOTREXATE SODIUM) 22.5 MG | Marketed | |
| 02491362 | METHOTREXATE SUBCUTANEOUS | ACCORD HEALTHCARE INC | Solution | Subcutaneous | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Marketed | |
| 02491303 | METHOTREXATE SUBCUTANEOUS | ACCORD HEALTHCARE INC | Solution | Subcutaneous | METHOTREXATE (METHOTREXATE SODIUM) 12.5 MG | Marketed | |
| 02491281 | METHOTREXATE SUBCUTANEOUS | ACCORD HEALTHCARE INC | Solution | Subcutaneous | METHOTREXATE (METHOTREXATE SODIUM) 10 MG | Marketed | |
| 02491311 | METHOTREXATE SUBCUTANEOUS | ACCORD HEALTHCARE INC | Solution | Subcutaneous | METHOTREXATE (METHOTREXATE SODIUM) 15 MG | Marketed | |
| 02491273 | METHOTREXATE SUBCUTANEOUS | ACCORD HEALTHCARE INC | Solution | Subcutaneous | METHOTREXATE (METHOTREXATE SODIUM) 7.5 MG | Approved | |
| 02454858 | METOJECT SUBCUTANEOUS | MEDEXUS PHARMACEUTICALS INC. | Solution | Subcutaneous | METHOTREXATE (METHOTREXATE SODIUM) 15 MG | Marketed | |
| 02454874 | METOJECT SUBCUTANEOUS | MEDEXUS PHARMACEUTICALS INC. | Solution | Subcutaneous | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Marketed | |
| 02454750 | METOJECT SUBCUTANEOUS | MEDEXUS PHARMACEUTICALS INC. | Solution | Subcutaneous | METHOTREXATE (METHOTREXATE SODIUM) 12.5 MG | Marketed | |
| 02454769 | METOJECT SUBCUTANEOUS | MEDEXUS PHARMACEUTICALS INC. | Solution | Subcutaneous | METHOTREXATE (METHOTREXATE SODIUM) 17.5 MG | Marketed | |
| 02454777 | METOJECT SUBCUTANEOUS | MEDEXUS PHARMACEUTICALS INC. | Solution | Subcutaneous | METHOTREXATE (METHOTREXATE SODIUM) 22.5 MG | Marketed | |
| 02454823 | METOJECT SUBCUTANEOUS | MEDEXUS PHARMACEUTICALS INC. | Solution | Subcutaneous | METHOTREXATE (METHOTREXATE SODIUM) 7.5 MG | Approved | |
| 02454831 | METOJECT SUBCUTANEOUS | MEDEXUS PHARMACEUTICALS INC. | Solution | Subcutaneous | METHOTREXATE (METHOTREXATE SODIUM) 10 MG | Marketed | |
| 02454866 | METOJECT SUBCUTANEOUS | MEDEXUS PHARMACEUTICALS INC. | Solution | Subcutaneous | METHOTREXATE (METHOTREXATE SODIUM) 20 MG | Marketed | |
| 02539659 | PMS-METHOTREXATE INJECTION | PHARMASCIENCE INC | Solution | Subcutaneous | METHOTREXATE (METHOTREXATE SODIUM) 22.5 MG | Marketed | |
| 02539608 | PMS-METHOTREXATE INJECTION | PHARMASCIENCE INC | Solution | Subcutaneous | METHOTREXATE (METHOTREXATE SODIUM) 10 MG | Marketed | |
| 02539616 | PMS-METHOTREXATE INJECTION | PHARMASCIENCE INC | Solution | Subcutaneous | METHOTREXATE (METHOTREXATE SODIUM) 12.5 MG | Marketed | |
| 02539624 | PMS-METHOTREXATE INJECTION | PHARMASCIENCE INC | Solution | Subcutaneous | METHOTREXATE (METHOTREXATE SODIUM) 15 MG | Marketed | |
| 02539632 | PMS-METHOTREXATE INJECTION | PHARMASCIENCE INC | Solution | Subcutaneous | METHOTREXATE (METHOTREXATE SODIUM) 17.5 MG | Marketed | |
| 02539640 | PMS-METHOTREXATE INJECTION | PHARMASCIENCE INC | Solution | Subcutaneous | METHOTREXATE (METHOTREXATE SODIUM) 20 MG | Marketed | |
| 02539667 | PMS-METHOTREXATE INJECTION | PHARMASCIENCE INC | Solution | Subcutaneous | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Marketed | |
| 02419173 | JAMP-METHOTREXATE | JAMP PHARMA CORPORATION | Solution | Intramuscular; Intra-Arterial; Intravenous; Intrathecal | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Cancelled Post Market | |
| 00614335 | METHOTREXATE DBL INJ 10MG/ML | DAVID BULL LABORATORIES (PTY) LTD. | Liquid | Intravenous | METHOTREXATE (METHOTREXATE SODIUM) 10 MG | Cancelled Post Market | |
| 00614327 | METHOTREXATE DBL INJ 2.5MG/ML | DAVID BULL LABORATORIES (PTY) LTD. | Liquid | Intravenous | METHOTREXATE (METHOTREXATE SODIUM) 2.5 MG | Cancelled Post Market | |
| 00614343 | METHOTREXATE DBL INJ 25MG/ML | DAVID BULL LABORATORIES (PTY) LTD. | Liquid | Intravenous | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Cancelled Post Market | |
| 02398427 | METHOTREXATE INJECTION USP | SANDOZ CANADA INCORPORATED | Solution | Intravenous; Intra-Arterial; Intramuscular | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Cancelled Post Market | |
| 02417626 | METHOTREXATE INJECTION, USP | STRIDES PHARMA CANADA INC | Solution | Intracerebroventricular; Intrathecal; Intramuscular; Intra-Arterial; Intravenous | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Dormant | |
| 02377624 | METHOTREXATE PF/SA INJECTION | SANDOZ CANADA INCORPORATED | Solution | Intramuscular; Intravenous; Intra-Arterial; Intrathecal | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Cancelled Pre Market | |
| 02084481 | METHOTREXATE SOD INJ 25MG/ML USP | DAVID BULL LABORATORIES (PTY) LTD. | Liquid | Intramuscular; Intra-Arterial; Intrathecal; Intravenous | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Cancelled Post Market | |
| 00410195 | METHOTREXATE SODIUM INJ 20MG | LEDERLE CYANAMID CANADA INC. | Powder For Solution | Intrathecal; Intravenous; Intramuscular | METHOTREXATE (METHOTREXATE SODIUM) 20 MG | Cancelled Post Market | |
| 00321397 | METHOTREXATE SODIUM INJ 25.0MG/ML | LEDERLE CYANAMID CANADA INC. | Liquid | Intravenous; Intrathecal; Intramuscular | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Cancelled Post Market | |
| 01911457 | METHOTREXATE SODIUM INJ 25MG/ML USP | DAVID BULL LABORATORIES (PTY) LTD. | Liquid | Intra-Arterial; Intrathecal; Intravenous; Intramuscular | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Cancelled Post Market | |
| 02161168 | METHOTREXATE SODIUM INJECTION USP | PFIZER CANADA ULC | Solution | Intraventricular; Intramuscular; Intra-Arterial; Intravenous; Intrathecal | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Cancelled Post Market | |
| 02170663 | METHOTREXATE-LIQ IM IV IAR INT IVR 25MG/ML | WYETH-AYERST CANADA INC. | Liquid | Intramuscular; Intravenous; Intrathecal; Intra-Arterial | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Cancelled Post Market | |
| 02170655 | METHOTREXATE-PWS IM IV IAR INT IVR 20MG/VIAL | WYETH-AYERST CANADA INC. | Powder For Solution | Intramuscular; Intravenous; Intrathecal; Intra-Arterial | METHOTREXATE (METHOTREXATE SODIUM) 20 MG | Cancelled Post Market | |
| 02320037 | METOJECT | MEDEXUS PHARMACEUTICALS INC. | Solution | Intra-Arterial; Intravenous; Intramuscular | METHOTREXATE (METHOTREXATE SODIUM) 10 MG | Cancelled Post Market | |
| 02320029 | METOJECT | MEDEXUS PHARMACEUTICALS INC. | Solution | Intra-Arterial; Intravenous; Intramuscular | METHOTREXATE (METHOTREXATE SODIUM) 7.5 MG | Cancelled Post Market | |
| 02304767 | METOJECT | MEDEXUS PHARMACEUTICALS INC. | Solution | Intra-Arterial; Intravenous; Intramuscular | METHOTREXATE (METHOTREXATE SODIUM) 20 MG | Cancelled Post Market | |
| 02320053 | METOJECT | MEDEXUS PHARMACEUTICALS INC. | Solution | Intra-Arterial; Intravenous; Intramuscular | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Cancelled Post Market | |
| 02320045 | METOJECT | MEDEXUS PHARMACEUTICALS INC. | Solution | Intravenous; Intramuscular; Intra-Arterial | METHOTREXATE (METHOTREXATE SODIUM) 15 MG | Cancelled Post Market | |
| 02546604 | NORDIMET | NORDIC GROUP B.V. | Solution | Subcutaneous | METHOTREXATE (METHOTREXATE SODIUM) 22.5 MG | Cancelled Pre Market | |
| 02546612 | NORDIMET | NORDIC GROUP B.V. | Solution | Subcutaneous | METHOTREXATE (METHOTREXATE SODIUM) 25 MG | Cancelled Post Market | |
| 02546531 | NORDIMET | NORDIC GROUP B.V. | Solution | Subcutaneous | METHOTREXATE (METHOTREXATE SODIUM) 7.5 MG | Cancelled Post Market | |
| 02546558 | NORDIMET | NORDIC GROUP B.V. | Solution | Subcutaneous | METHOTREXATE (METHOTREXATE SODIUM) 10 MG | Cancelled Post Market | |
| 02546574 | NORDIMET | NORDIC GROUP B.V. | Solution | Subcutaneous | METHOTREXATE (METHOTREXATE SODIUM) 15 MG | Cancelled Post Market | |
| 02546566 | NORDIMET | NORDIC GROUP B.V. | Solution | Subcutaneous | METHOTREXATE (METHOTREXATE SODIUM) 12.5 MG | Cancelled Pre Market | |
| 02546590 | NORDIMET | NORDIC GROUP B.V. | Solution | Subcutaneous | METHOTREXATE (METHOTREXATE SODIUM) 20 MG | Cancelled Post Market | |
| 02546582 | NORDIMET | NORDIC GROUP B.V. | Solution | Subcutaneous | METHOTREXATE (METHOTREXATE SODIUM) 17.5 MG | Cancelled Pre Market | |
| 02244798 | RATIO-METHOTREXATE SODIUM | TEVA CANADA LIMITED | Tablet | Oral | METHOTREXATE (METHOTREXATE SODIUM) 2.5 MG | Cancelled Post Market | |
| 02171767 | RHEUMATREX-TAB 2.5MG | WYETH-AYERST CANADA INC. | Tablet | Oral | METHOTREXATE (METHOTREXATE SODIUM) 2.5 MG | Cancelled Post Market |
Browse other molecules: